Assessment of clinical worsening end points as a surrogate for mortality in pulmonary arterial hypertension: a systematic review and meta-analysis of randomized …
Background: Clinical worsening (CW) is a composite end point commonly used in
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …
Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized …
É Tremblay, C Gosselin, V Mai, AC Lajoie, R Kilo… - Circulation, 2022 - Am Heart Assoc
BACKGROUND: Clinical worsening (CW) is a composite end point commonly used in
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …
Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized …
É Tremblay, C Gosselin, V Mai, AC Lajoie, R Kilo… - …, 2022 - ingentaconnect.com
Background: Clinical worsening (CW) is a composite end point commonly used in
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …
pulmonary arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of …
Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized …
É Tremblay, C Gosselin, V Mai, AC Lajoie… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Clinical worsening (CW) is a composite end point commonly used in pulmonary
arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of CW for …
arterial hypertension (PAH) trials. We aimed to assess the trial-level surrogacy of CW for …